Documents and evidence
Accreditation and scope
Accreditation covers specified activities. Check the current certificate and exact test/matrix scope; a general accreditation claim does not validate every report or product.
Checked 2026-10-25
A clearer reading
Cannabinoids, label units and laboratory language, with sources you can check.
Documents and evidence
Accreditation covers specified activities. Check the current certificate and exact test/matrix scope; a general accreditation claim does not validate every report or product.
Checked 2026-10-25
Cannabinoids
Acidic and neutral cannabinoids are recorded separately. Heating can change their composition; use the report’s named analytes and stated conversion formula.
Checked 2026-10-25
Commerce
A commercial relationship that may pay the publisher for a referral or qualifying purchase. The connection should be explained near relevant links and must not alter evidence facts.
Checked 2026-10-25
Research
Research in whole animals under experimental conditions. Findings can guide hypotheses but are not evidence that a retail product benefits a person.
Checked 2026-10-25
Labels and units
A vendor formulation description often marketed with THC removed. It does not prove zero THC or replace a batch result and its detection threshold.
Checked 2026-10-25
Labels and units
Some methods combine delta-9 THC with 0.877 times THCA to express potential THC. Check the report’s actual formula and basis; this alone does not establish destination eligibility.
Checked 2026-10-25
Cannabinoids
A member of the chemical group discussed in cannabis research. A compound name does not establish the composition, benefit or safety of a finished product.
Checked 2026-10-25
Cannabinoids
A phytocannabinoid distinct from CBD, CBG and THC. Cell-channel observations involving CBC are mechanistic evidence rather than human treatment results.
Checked 2026-10-25
Cannabinoids
A cannabinoid distinct from THC. Research involving a defined CBD preparation does not make every CBD-labelled retail product equivalent.
Checked 2026-10-25
Cannabinoids
A phytocannabinoid studied in laboratory models and a small human field trial. CBG and its acidic precursor CBGA are distinct compounds.
Checked 2026-10-25
Cannabinoids
A cannabinoid formed through THC oxidation and studied in sleep research. Preliminary or mixed study findings do not establish a general sleep-treatment claim.
Checked 2026-10-25
Documents and evidence
A document describing a sample and its reported analyses. Read sample identity, dates, laboratory, methods, units, limits and panel coverage together.
Checked 2026-10-25
Labels and units
CBD mass divided by liquid volume. A 1500mg label claim in 30ml corresponds to 50mg/ml; concentration is different from the package’s total mass.
Checked 2026-10-25
Labels and units
A result expressed relative to dry material. Moisture and sample preparation affect the basis; compare results only when their reporting bases agree.
Checked 2026-10-25
Labels and units
A vendor formulation description for a mixture that can include THC. It does not specify the current batch’s CBD, THC or contaminant amounts.
Checked 2026-10-25
Testing
Gas-based separation coupled to mass detection. The method name alone does not establish which compounds were measured, their reporting limits or a complete contaminant screen.
Checked 2026-10-25
Labels and units
The mass of an extract or blend may contain several components. Do not substitute it for an individually declared CBD-only mass or assign the difference to an unreported cannabinoid.
Checked 2026-10-25
Testing
A separation method using a liquid mobile phase. The acronym alone does not specify every detector, validated analyte, reporting limit or sample-preparation step.
Checked 2026-10-25
Research
Research involving people. Study design, population, comparator and formulation determine what a result can address; the word human alone does not imply strong evidence.
Checked 2026-10-25
Testing
A plasma-based mass-spectrometry method for elemental analysis, including trace metals. It is distinct from cannabinoid potency testing and does not by itself provide a complete safety assessment.
Checked 2026-10-25
Research
Experiments outside a whole living organism, such as cell cultures or isolated tissues. Activity in these systems does not establish clinical benefit.
Checked 2026-10-25
Documents and evidence
Who acquired and submitted the tested sample matters. A third-party laboratory testing a vendor-submitted sample is not automatically independent retail sampling.
Checked 2026-10-25
Labels and units
A formulation term for an isolated cannabinoid. Treat the named compound and amount as label claims until supported by a report for the relevant package.
Checked 2026-10-25
Documents and evidence
This site’s document check against a specific issuing-lab record. It is separate from product/package matching, independently purchased sampling and current-shipping-lot confirmation.
Checked 2026-10-25
Testing
Liquid-chromatography separation coupled to mass detection; tandem MS examines selected ion relationships. Check the exact analytes, sample preparation and validated method scope.
Checked 2026-10-25
Testing
A method-specific boundary for detecting a signal with stated confidence. Detection does not necessarily provide a reliable quantitative amount.
Checked 2026-10-25
Testing
The boundary of quantities that a procedure can measure to its stated performance requirement. A below-LOQ result must not be converted to zero.
Checked 2026-10-25
Documents and evidence
An identifier for a defined material group. A historical report with a matching product name does not establish which lot a vendor currently ships.
Checked 2026-10-25
Labels and units
When both express mass per mass, 1% equals 10mg/g. A percentage needs a stated basis; it is not automatically an amount per bottle.
Checked 2026-10-25
Testing
Evidence that a procedure meets requirements for its intended use. Relevant characteristics can include selectivity, working range, detection/quantification limits and precision.
Checked 2026-10-25
Testing
A reporting statement tied to the method’s detection criterion. ND does not mean numerical zero; retain the report’s threshold and analyte-specific wording.
Checked 2026-10-25
Documents and evidence
The accessible original document and supporting results, rather than only a vendor badge or typed claim. Accessibility alone does not confirm authenticity or current inventory.
Checked 2026-10-25
Labels and units
An amount tied to the label’s serving definition. Multiply by explicit servings and exact package count only when those quantities are supported. This is label arithmetic.
Checked 2026-10-25
Research
The main prespecified endpoint is distinguished from additional outcomes. A secondary signal does not replace a null or inconclusive primary result.
Checked 2026-10-25
Research
A public record describing a planned or ongoing study. Registration, completion status, posted results and a peer-reviewed publication are different pieces of evidence.
Checked 2026-10-25
Testing
A named group of analyses, such as potency, pesticides, metals or microbes. A panel not reported or not tested is not a passing panel.
Checked 2026-10-25
Cannabinoids
THC is associated with cannabis intoxication. Read the named analyte, amount, units and reporting threshold; a spectrum label cannot supply those measurements.
Checked 2026-10-25
Labels and units
The CBD amount in the complete offered package. Price per mg divides that package’s comparable price by CBD alone, excluding THC and total extract.
Checked 2026-10-25
No terms match. Try another spelling or a broader category.
Copy a note and share it with the person who sent this preview. This page does not send or store your note.